NSE: ZYDUSWELL | BSE: 531335

Expensive Performer

Download real time

456.05 0.05 (0.01%)

52.71% Gain from 52W Low

384.3K NSE+BSE Volume

NSE 13 Oct, 2025 3:31 PM (IST)

14,509.7

Market Cap

High in industry

0.6

Beta 1Year

Very Low volatility

Zydus Wellness Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for ZYDUSWELL, BSE:531335 Zydus Wellness Ltd.

Zydus Wellness Ltd.

13 Feb 2024, 12:00AM

456.05

0.01%

First Light | Amber Enterprises, CPI And IIP, Credit Composition, Hero Motocorp, Thermax, Bandhan Bank, Indraprastha Gas, Zydus Wellness

Hold: Zydus Wellness Ltd.

Target

BOB Capital Markets Ltd.

AMBER: Persistent near-term challenges; cut to SELL. CPI and IIP: Still some pain points on inflation. Credit Composition: Study on personal loans. HMCL: Healthy quarter but positives priced in. TMX: Improving order outlook; maintain HOLD. BANDHAN: Recovery on track. IGL: Legacy UP, new GAs can offset slowdown, reiterate BUY. ZYWL: Seasonally weak quarter

Zydus Wellness Ltd. is trading above its 200 day SMA of 388.0

Zydus Wellness Ltd.

07 Nov 2023

456.05

0.01%

Zydus Wellness (HOLD): Subdued growth in a seasonally weak quarter

Hold: Zydus Wellness Ltd.

Target

BOB Capital Markets Ltd.

Flattish volume growth in Q2 owing to muted performance in glucose and sweetener categories

Number of FII/FPI investors increased from 126 to 135 in Jun 2025 qtr.

Zydus Wellness Ltd.

06 Nov 2023

456.05

0.01%

Zydus Wellness

Buy: Zydus Wellness Ltd.

Target

Sharekhan

Zydus Wellness Ltd. is trading above its 200 day SMA of 388.0

Zydus Wellness Ltd.

03 Aug 2023

456.05

0.01%

Decent underlying growth though margin remains under pressure

Buy: Zydus Wellness Ltd.

Target

ICICI Securities Limited

Zydus witnessed a decent performance with double-digit revenue growth (~5% volume growth), excluding the impact of unseasonal rains (~1% YoY reported revenue growth) on Glucon D brand which has higher salience in Q1. Nycil, Nutralite and Everyuth exhibited a good performance, while Complan witnessed good consumer offtakes.

Zydus Wellness Ltd. has gained 30.44% in the last 6 Months

Zydus Wellness Ltd.

23 May 2023

456.05

0.01%

Zydus Wellness (HOLD): Price-led growth in Q4; HFD category a concern

Hold: Zydus Wellness Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Q4 revenue grew 11.4% YoY on the back of continuous price hikes; volume growth muted at 4%

Number of FII/FPI investors increased from 126 to 135 in Jun 2025 qtr.

Zydus Wellness Ltd.

18 May 2023

456.05

0.01%

Zydus Wellness

Hold: Zydus Wellness Ltd.

Recommendation Target

ICICI Direct

Zydus Wellness Ltd. is trading below its 30 day SMA of 480.5

Zydus Wellness Ltd.

18 May 2023

456.05

0.01%

Decent performance in the given context

Buy: Zydus Wellness Ltd.

Target

ICICI Securities Limited

Zydus reported a decent revenue growth of ~11% YoY with volume growth of ~4% YoY. Gross margin was flat YoY at 51% in Q4 despite significant dairy inflation (still below FY21 levels). Price hike of 7.8% has been implemented to recover gross margins further (better mix and moderation in dairy inflation are other drivers).